This clinical trial investigated the effect of postmenopausal hormone therapy (HRT) on inflammation-sensitive proteins, which are known to predict cardiovascular disease outcomes. The study found that HRT significantly reduced these proteins, suggesting a potential mechanism for lowering cardiovascular risk in postmenopausal women. However, the effect was dependent on the type
